| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 68,494 | 71,049 | 72,512 | 72,437 | | Cost of Revenue | 19,085 | 19,084 | 18,929 | 19,040 | | | Gross Profit | 49,409 | 51,965 | 53,583 | 53,397 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,662 | 7,308 | 7,053 | 10,210 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 22,211 | 22,183 | 22,609 | 21,595 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,536 | 22,474 | 23,921 | 21,592 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,620 | 503 | 70 | (285) | | Earnings Before Interest And Taxes | 23,156 | 22,977 | 23,991 | 19,644 | | Interest Expense | 10,926 | 11,897 | 12,218 | 11,478 | | Income Before Tax | 12,230 | 11,080 | 11,773 | 8,166 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (1,144) |
-
|
-
| (1,663) | | | | Net Income From Continuing Ops | 11,086 | 11,080 | 11,773 | 8,166 | | | Non-recurring Events | | Discontinued Operations |
-
| 2,261 |
-
| 128 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,086 | 13,341 | 11,773 | 8,294 | | Preferred Stock And Other Adjustments | (2,975) | (4,226) | (4,196) | (2,402) | | | Net Income Applicable To Common Shares | $8,111 | $9,115 | $7,577 | $5,892 |
|
0.31% Nasdaq 0.00%
Income Statement
